StockData
Elevance Health, Inc. logo

Elevance Health, Inc.

ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3014% below fair value
$413.60−6.47 (-1.54%)

Close on Nov 2, 2026Market cap $89.70BP/E 18.4Yield –

Elevance Health Total Carelon by Year

Total Carelon — Cost of Products Sold (ASU 2023-07) ($M)

Elevance Health Total Carelon: $40,077M in FY2025, up 21.5% from a year earlier.

Latest, FY2025
40,077
Period ended Dec 31, 2025
Change on a year earlier
+21.5%
32,978 in FY2024
History
4 years
Since FY2022
Sources
2
Documents cited below

Where the FY2025 figure comes from

“|| Cost of products sold | — | 40,077 | — | 40,077 | — | ( 18,899 ) | 21,178”

Source: 10-K (FY2025, 2026-02-06) ↗

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedTotal Carelon — Cost of Products Sold (ASU 2023-07) ($M)Year on yearSource
FY2025Dec 31, 202540,077+21.5%10-K (FY2025, 2026-02-06) ↗
FY2024Dec 31, 202432,978+4.4%10-K (FY2025, 2026-02-06) ↗
FY2023Dec 31, 202331,588+19.0%10-K (FY2025, 2026-02-06) ↗
FY2022Dec 31, 202226,544–10-K (FY2024, 2025-02-20) ↗

Cite this data

StockData. (2026). Elevance Health Total Carelon ($M), annual FY2022–FY2025 [Data set]. Compiled from Elevance Health SEC filings and investor materials. https://stockdatahq.com/stocks/elv/kpis/seg-carelon-total-cost-of-products

See every metric in the Elevance Health KPI table. Data updated Oct 28, 2026.